Publizoom

INTEC PHARMA s.r.o.

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won
3
Amount won alone
€2,539,208 excl. VAT
Shared contracts
1 (multi-supplier framework agreements)
Period
11 September 2026 – 16 October 2026

Its main clients

Where and what

Supplies · 3

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned endContractCurrent holderAmount
18 August 2028
re-tender around February 2028
Antitrombotické činidlá
Univerzitná nemocnica Martin
MED - ART, spol. s r.o.
INTEC PHARMA s.r.o.
UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť
5 bids received
€748,345
12 October 2029
re-tender around April 2029
Lieky ATC skupiny B02BD04 Koagulačný faktor IX
Všeobecná zdravotná poisťovňa, a.s. framework agreement
INTEC PHARMA s.r.o.
1 bid received
€1,026,846
12 October 2029
re-tender around April 2029
Lieky ATC skupiny B02BD02 Koagulačný faktor VIII, parent rekomb (simoktokog alfa)
Všeobecná zdravotná poisťovňa, a.s. framework agreement
INTEC PHARMA s.r.o.
1 bid received
€1,512,362

Contracts won

DateContractBuyerAmount
16/10/2026 Lieky ATC skupiny B02BD04 Koagulačný faktor IX Všeobecná zdravotná poisťovňa, a.s. €1,026,846
16/10/2026 Lieky ATC skupiny B02BD02 Koagulačný faktor VIII, parent rekomb (simoktokog alfa) Všeobecná zdravotná poisťovňa, a.s. €1,512,362
11/09/2026 Antitrombotické činidlá Univerzitná nemocnica Martin €748,345
shared by 3

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.